Organogenesis (NASDAQ:ORGO – Get Free Report) was downgraded by investment analysts at Wall Street Zen from a “sell” rating to a “strong sell” rating in a report released on Saturday. A number of other equities analysts also recently issued reports on ORGO. BTIG Research downgraded shares of Organogenesis from a “buy” rating to a “neutral” [...]